A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a randomised, double-blind, positive drug parallel controlled clinical trial in China. In the trial, it is planned to enroll 88 subjects, randomized to two treatment groups in a ratio of 1:1 to receive the test drug and the positive control.
Epistemonikos ID: 7c4a05fe3af220d4c22cb47508c10d537919255f
First added on: May 06, 2024